Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Torres-Ferrus

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Neurology|November 3, 2018
OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication OveruseEdoardo Caronna, Victor José Gallardo, Natalia Hernández-Beltrán, et al.
The Journal of Headache and Pain|April 18, 2024
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterizationAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Annals of Neurology|September 2, 2022
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in MigraineAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Headache|January 28, 2026
Response to: Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assaysAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Cephalalgia : an International Journal of Headache|October 4, 2021
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacksAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
European Journal of Neurology|April 11, 2023
Patterns of response to anti-calcitonin gene-related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcomeMarta Torres-Ferrus, Victor J Gallardo, Alicia Alpuente, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|January 11, 2025
Quality of Headache Management in InpatientsEulalia Gine-Cipres, Marta Torres-Ferrus, Victor J Gallardo, et al.
Headache|February 19, 2020
How Does Migraine Change After 10 Years? A Clinical Cohort Follow-Up AnalysisEdoardo Caronna, Victor José Gallardo, Elena Fonseca, et al.
The Journal of Headache and Pain|February 12, 2024
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age populationCarlos Lazaro-Hernandez, Edoardo Caronna, Joana Rosell-Mirmi, et al.
Revista De Neurologia|March 31, 2026
Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA AdministrationEulalia Gine-Cipres, Marta Torres-Ferrus, Víctor J Gallardo, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Neurology|November 3, 2018
OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication OveruseEdoardo Caronna, Victor José Gallardo, Natalia Hernández-Beltrán, et al.
The Journal of Headache and Pain|April 18, 2024
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterizationAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Annals of Neurology|September 2, 2022
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in MigraineAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Headache|January 28, 2026
Response to: Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assaysAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Cephalalgia : an International Journal of Headache|October 4, 2021
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacksAlicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
European Journal of Neurology|April 11, 2023
Patterns of response to anti-calcitonin gene-related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcomeMarta Torres-Ferrus, Victor J Gallardo, Alicia Alpuente, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|January 11, 2025
Quality of Headache Management in InpatientsEulalia Gine-Cipres, Marta Torres-Ferrus, Victor J Gallardo, et al.
Headache|February 19, 2020
How Does Migraine Change After 10 Years? A Clinical Cohort Follow-Up AnalysisEdoardo Caronna, Victor José Gallardo, Elena Fonseca, et al.
The Journal of Headache and Pain|February 12, 2024
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age populationCarlos Lazaro-Hernandez, Edoardo Caronna, Joana Rosell-Mirmi, et al.
Revista De Neurologia|March 31, 2026
Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA AdministrationEulalia Gine-Cipres, Marta Torres-Ferrus, Víctor J Gallardo, et al.
Pageof 4